

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.41503126 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.41503126 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.84969305 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.06149877 |
| 5 | signal peptide processing (GO:0006465) | 4.67750693 |
| 6 | COPII vesicle coating (GO:0048208) | 4.55511022 |
| 7 | ribosome assembly (GO:0042255) | 4.38313123 |
| 8 | exocrine pancreas development (GO:0031017) | 4.24367396 |
| 9 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.17017414 |
| 10 | * positive regulation of nuclease activity (GO:0032075) | 4.11713426 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 4.01505081 |
| 12 | nuclear pore complex assembly (GO:0051292) | 4.00152470 |
| 13 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 3.90657118 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.88204922 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.88204922 |
| 16 | * regulation of nuclease activity (GO:0032069) | 3.79618181 |
| 17 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.79596390 |
| 18 | * cellular response to unfolded protein (GO:0034620) | 3.78934886 |
| 19 | establishment of integrated proviral latency (GO:0075713) | 3.73101471 |
| 20 | cysteine metabolic process (GO:0006534) | 3.68018241 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 3.66059451 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.66059451 |
| 23 | 4-hydroxyproline metabolic process (GO:0019471) | 3.65414539 |
| 24 | proteasome assembly (GO:0043248) | 3.63662405 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.61959271 |
| 26 | L-phenylalanine catabolic process (GO:0006559) | 3.61959271 |
| 27 | * cellular response to topologically incorrect protein (GO:0035967) | 3.58446569 |
| 28 | * ER-nucleus signaling pathway (GO:0006984) | 3.57325842 |
| 29 | valine metabolic process (GO:0006573) | 3.57108754 |
| 30 | sequestering of metal ion (GO:0051238) | 3.52695527 |
| 31 | establishment of viral latency (GO:0019043) | 3.45893922 |
| 32 | nuclear pore organization (GO:0006999) | 3.41607792 |
| 33 | protein maturation by protein folding (GO:0022417) | 3.40131420 |
| 34 | protein carboxylation (GO:0018214) | 3.37719286 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.37719286 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.35285792 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.33578100 |
| 38 | * response to endoplasmic reticulum stress (GO:0034976) | 3.29591572 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.26440692 |
| 40 | serine family amino acid biosynthetic process (GO:0009070) | 3.25538451 |
| 41 | mitotic chromosome condensation (GO:0007076) | 3.24750997 |
| 42 | cell adhesion mediated by integrin (GO:0033627) | 3.23865718 |
| 43 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.22488247 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.21547212 |
| 45 | negative regulation of ligase activity (GO:0051352) | 3.20336637 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.20336637 |
| 47 | glycine metabolic process (GO:0006544) | 3.18047448 |
| 48 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.15724411 |
| 49 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.14065267 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.12411753 |
| 51 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.11046205 |
| 52 | peptidyl-asparagine modification (GO:0018196) | 3.10972882 |
| 53 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.09233890 |
| 54 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.09023260 |
| 55 | skin morphogenesis (GO:0043589) | 3.08616504 |
| 56 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.08357696 |
| 57 | mitotic metaphase plate congression (GO:0007080) | 3.06539949 |
| 58 | pore complex assembly (GO:0046931) | 3.04553170 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 3.02491793 |
| 60 | regulation of translational termination (GO:0006449) | 3.01405382 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 3.00897164 |
| 62 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.96884919 |
| 63 | lysine metabolic process (GO:0006553) | 2.96865045 |
| 64 | lysine catabolic process (GO:0006554) | 2.96865045 |
| 65 | * response to unfolded protein (GO:0006986) | 2.96779216 |
| 66 | glyoxylate metabolic process (GO:0046487) | 2.91635760 |
| 67 | protein N-linked glycosylation (GO:0006487) | 2.89368923 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 2.87928756 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87224997 |
| 70 | * response to topologically incorrect protein (GO:0035966) | 2.86358059 |
| 71 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.83802662 |
| 72 | regulation of vitamin metabolic process (GO:0030656) | 2.82458686 |
| 73 | homocysteine metabolic process (GO:0050667) | 2.80458114 |
| 74 | apoptotic cell clearance (GO:0043277) | 2.78685779 |
| 75 | pentose-phosphate shunt (GO:0006098) | 2.78014076 |
| 76 | ER overload response (GO:0006983) | 2.77603157 |
| 77 | regulation of protein activation cascade (GO:2000257) | 2.75049673 |
| 78 | vesicle coating (GO:0006901) | 2.74160290 |
| 79 | peptide catabolic process (GO:0043171) | 2.73338636 |
| 80 | regulation of translational fidelity (GO:0006450) | 2.71495705 |
| 81 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.71385804 |
| 82 | mitotic sister chromatid segregation (GO:0000070) | 2.70598532 |
| 83 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.70505898 |
| 84 | peptidyl-proline hydroxylation (GO:0019511) | 2.70498868 |
| 85 | tetrahydrofolate metabolic process (GO:0046653) | 2.69456649 |
| 86 | L-serine metabolic process (GO:0006563) | 2.68605832 |
| 87 | alpha-linolenic acid metabolic process (GO:0036109) | 2.67403614 |
| 88 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.66388473 |
| 89 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.66388473 |
| 90 | tRNA aminoacylation for protein translation (GO:0006418) | 2.65323595 |
| 91 | regulation of complement activation (GO:0030449) | 2.64917046 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.64398805 |
| 93 | folic acid metabolic process (GO:0046655) | 2.64093620 |
| 94 | mitotic nuclear envelope disassembly (GO:0007077) | 2.63192092 |
| 95 | establishment of chromosome localization (GO:0051303) | 2.62786398 |
| 96 | de novo protein folding (GO:0006458) | 2.62724119 |
| 97 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62684833 |
| 98 | metaphase plate congression (GO:0051310) | 2.62558266 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.62428658 |
| 100 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.62428658 |
| 101 | complement activation, classical pathway (GO:0006958) | 2.61774451 |
| 102 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.60228618 |
| 103 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.60228618 |
| 104 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.60228618 |
| 105 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.59793738 |
| 106 | proline biosynthetic process (GO:0006561) | 2.59064075 |
| 107 | NADPH regeneration (GO:0006740) | 2.58010975 |
| 108 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.56893861 |
| 109 | cellular modified amino acid catabolic process (GO:0042219) | 2.56163659 |
| 110 | tryptophan metabolic process (GO:0006568) | 2.55845328 |
| 111 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.55779727 |
| 112 | bile acid biosynthetic process (GO:0006699) | 2.55556407 |
| 113 | complement activation, alternative pathway (GO:0006957) | 2.55242687 |
| 114 | regulation of fibrinolysis (GO:0051917) | 2.55112098 |
| 115 | DNA strand elongation (GO:0022616) | 2.54637473 |
| 116 | regulation of RNA export from nucleus (GO:0046831) | 2.54324197 |
| 117 | protein localization to chromosome, centromeric region (GO:0071459) | 2.53860962 |
| 118 | intestinal absorption (GO:0050892) | 2.53855359 |
| 119 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.53201251 |
| 120 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.52967936 |
| 121 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.52281833 |
| 122 | amino acid activation (GO:0043038) | 2.51438591 |
| 123 | tRNA aminoacylation (GO:0043039) | 2.51438591 |
| 124 | de novo posttranslational protein folding (GO:0051084) | 2.51036321 |
| 125 | pinocytosis (GO:0006907) | 2.50385363 |
| 126 | one-carbon metabolic process (GO:0006730) | 2.50090770 |
| 127 | kynurenine metabolic process (GO:0070189) | 2.49676434 |
| 128 | cell redox homeostasis (GO:0045454) | 2.49620260 |
| 129 | glycosphingolipid catabolic process (GO:0046479) | 2.49094659 |
| 130 | protein autoprocessing (GO:0016540) | 2.49031247 |
| 131 | folic acid-containing compound metabolic process (GO:0006760) | 2.48736263 |
| 132 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48711524 |
| 133 | positive regulation of ligase activity (GO:0051351) | 2.48498184 |
| 134 | membrane disassembly (GO:0030397) | 2.48002860 |
| 135 | nuclear envelope disassembly (GO:0051081) | 2.48002860 |
| 136 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47782011 |
| 137 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.46847594 |
| 138 | ribosome biogenesis (GO:0042254) | 2.45675187 |
| 139 | tryptophan catabolic process (GO:0006569) | 2.45222287 |
| 140 | indole-containing compound catabolic process (GO:0042436) | 2.45222287 |
| 141 | indolalkylamine catabolic process (GO:0046218) | 2.45222287 |
| 142 | DNA unwinding involved in DNA replication (GO:0006268) | 2.44542568 |
| 143 | mitotic nuclear envelope reassembly (GO:0007084) | 2.44476831 |
| 144 | nuclear envelope reassembly (GO:0031468) | 2.44476831 |
| 145 | cellular copper ion homeostasis (GO:0006878) | 2.44452280 |
| 146 | tricarboxylic acid metabolic process (GO:0072350) | 2.43275241 |
| 147 | chaperone-mediated protein folding (GO:0061077) | 2.42094114 |
| 148 | protein localization to kinetochore (GO:0034501) | 2.41576934 |
| 149 | regulation of ligase activity (GO:0051340) | 2.40702674 |
| 150 | sister chromatid segregation (GO:0000819) | 2.40482645 |
| 151 | regulation of mitotic spindle organization (GO:0060236) | 2.40046713 |
| 152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39454971 |
| 153 | regulation of translation in response to stress (GO:0043555) | 2.39202814 |
| 154 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.38255033 |
| 155 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.38255033 |
| 156 | aromatic amino acid family metabolic process (GO:0009072) | 2.37114644 |
| 157 | cellular protein complex localization (GO:0034629) | 2.36442204 |
| 158 | complement activation (GO:0006956) | 2.35979843 |
| 159 | regulation of plasminogen activation (GO:0010755) | 2.35349892 |
| 160 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.35273294 |
| 161 | glycolipid catabolic process (GO:0019377) | 2.35196661 |
| 162 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.33688295 |
| 163 | maternal placenta development (GO:0001893) | 2.33443781 |
| 164 | plasma lipoprotein particle clearance (GO:0034381) | 2.32390633 |
| 165 | urea cycle (GO:0000050) | 2.30509952 |
| 166 | urea metabolic process (GO:0019627) | 2.30509952 |
| 167 | GDP-mannose metabolic process (GO:0019673) | 2.30424073 |
| 168 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.29882314 |
| 169 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.29137433 |
| 170 | serine family amino acid catabolic process (GO:0009071) | 2.28623008 |
| 171 | transcytosis (GO:0045056) | 2.27788156 |
| 172 | fibrinolysis (GO:0042730) | 2.26942891 |
| 173 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.26789658 |
| 174 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.23080139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.79796568 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25638821 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.14606764 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81943742 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65956218 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.65523409 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58904614 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.51432222 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.48578807 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.47238144 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44335907 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43932230 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38885894 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.20607794 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20296700 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.13693365 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.13015109 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.08145468 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07071113 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03034957 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94437133 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91032034 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89153957 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.86071918 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80560287 |
| 26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74098639 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72982166 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.70390278 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69650090 |
| 30 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.66693128 |
| 31 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66573586 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66069099 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.63494521 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63331200 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61509794 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58901541 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.58077569 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55448427 |
| 39 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54780056 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54453121 |
| 41 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.53924214 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53728920 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52878467 |
| 44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.50776655 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50385951 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50207046 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50039249 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.49857977 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48078651 |
| 50 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.47923691 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47532797 |
| 52 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45843158 |
| 53 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.45444594 |
| 54 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44475045 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42029667 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41363104 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39534568 |
| 58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39380737 |
| 59 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.38609685 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38255068 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.37746798 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36212699 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35587587 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35388246 |
| 65 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35047328 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33398122 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33184493 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32817871 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32026212 |
| 70 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.30719358 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.28625925 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.28492999 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26913089 |
| 74 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26543331 |
| 75 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.26364699 |
| 76 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25794394 |
| 77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25048424 |
| 78 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24985357 |
| 79 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24407374 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23910826 |
| 81 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23883821 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23545666 |
| 83 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.23356703 |
| 84 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22802223 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22695658 |
| 86 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22598542 |
| 87 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.22372001 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22102478 |
| 89 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.21941576 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21200597 |
| 91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20981851 |
| 92 | MYB_26560356_Chip-Seq_TH2_Human | 1.20063174 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18018907 |
| 94 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16070804 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14554897 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13207865 |
| 97 | MYB_26560356_Chip-Seq_TH1_Human | 1.12195238 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11394309 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11161247 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10461025 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10461025 |
| 102 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10225807 |
| 103 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09275078 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07579246 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07288250 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06965103 |
| 107 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.06958236 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06899638 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.06889518 |
| 110 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06639784 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06581923 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06417824 |
| 113 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05376654 |
| 114 | MAF_26560356_Chip-Seq_TH1_Human | 1.04122207 |
| 115 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04044131 |
| 116 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03997694 |
| 117 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03540822 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03462645 |
| 119 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02645099 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02641885 |
| 121 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02577326 |
| 122 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02375118 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02325127 |
| 124 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01548038 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00957855 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00895010 |
| 127 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00877311 |
| 128 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00404019 |
| 129 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00088206 |
| 130 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98619668 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98218672 |
| 132 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98017613 |
| 133 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97670364 |
| 134 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.97575409 |
| 135 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97363352 |
| 136 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97324368 |
| 137 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97211360 |
| 138 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97095316 |
| 139 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96207300 |
| 140 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.95326749 |
| 141 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.94151845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.63870175 |
| 2 | MP0005360_urolithiasis | 3.29655073 |
| 3 | MP0005365_abnormal_bile_salt | 3.22911685 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 2.78833219 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.68254439 |
| 6 | MP0005083_abnormal_biliary_tract | 2.61291818 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.53922599 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.53803464 |
| 9 | MP0003941_abnormal_skin_development | 2.47818250 |
| 10 | MP0009840_abnormal_foam_cell | 2.39266646 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.38082848 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.37189549 |
| 13 | MP0005220_abnormal_exocrine_pancreas | 2.35027129 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.29859324 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.17620088 |
| 16 | MP0003077_abnormal_cell_cycle | 2.13922094 |
| 17 | MP0004272_abnormal_basement_membrane | 2.10959879 |
| 18 | MP0003252_abnormal_bile_duct | 2.08325015 |
| 19 | MP0006054_spinal_hemorrhage | 2.05685383 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.03505106 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.99041632 |
| 22 | MP0008932_abnormal_embryonic_tissue | 1.90169809 |
| 23 | MP0003693_abnormal_embryo_hatching | 1.82459578 |
| 24 | MP0001730_embryonic_growth_arrest | 1.78009690 |
| 25 | MP0005451_abnormal_body_composition | 1.73377219 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70088409 |
| 27 | MP0009697_abnormal_copulation | 1.65751504 |
| 28 | MP0002796_impaired_skin_barrier | 1.59750646 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.59339425 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.58661453 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.55369567 |
| 32 | MP0005501_abnormal_skin_physiology | 1.52069444 |
| 33 | MP0003195_calcinosis | 1.51188725 |
| 34 | MP0000350_abnormal_cell_proliferation | 1.51102044 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.49734003 |
| 36 | MP0002877_abnormal_melanocyte_morpholog | 1.48386872 |
| 37 | MP0003186_abnormal_redox_activity | 1.46710569 |
| 38 | MP0004264_abnormal_extraembryonic_tissu | 1.45015021 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.44904490 |
| 40 | MP0008058_abnormal_DNA_repair | 1.42941437 |
| 41 | MP0000609_abnormal_liver_physiology | 1.39764673 |
| 42 | MP0003868_abnormal_feces_composition | 1.39384574 |
| 43 | MP0005332_abnormal_amino_acid | 1.39382385 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.39076424 |
| 45 | MP0003566_abnormal_cell_adhesion | 1.38390381 |
| 46 | MP0003436_decreased_susceptibility_to | 1.38060608 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.37350113 |
| 48 | MP0002254_reproductive_system_inflammat | 1.36011683 |
| 49 | MP0001727_abnormal_embryo_implantation | 1.34031140 |
| 50 | MP0001835_abnormal_antigen_presentation | 1.33601667 |
| 51 | MP0008260_abnormal_autophagy | 1.32977549 |
| 52 | MP0008057_abnormal_DNA_replication | 1.30196691 |
| 53 | MP0004233_abnormal_muscle_weight | 1.30038273 |
| 54 | MP0005023_abnormal_wound_healing | 1.27365654 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.27099308 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.24742974 |
| 57 | MP0003786_premature_aging | 1.23748481 |
| 58 | MP0003303_peritoneal_inflammation | 1.23114009 |
| 59 | MP0001216_abnormal_epidermal_layer | 1.22373985 |
| 60 | MP0005380_embryogenesis_phenotype | 1.22065811 |
| 61 | MP0001672_abnormal_embryogenesis/_devel | 1.22065811 |
| 62 | MP0002080_prenatal_lethality | 1.21562538 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.20805854 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.20182901 |
| 65 | MP0006082_CNS_inflammation | 1.19773203 |
| 66 | MP0000685_abnormal_immune_system | 1.19441182 |
| 67 | MP0002693_abnormal_pancreas_physiology | 1.16248964 |
| 68 | MP0003984_embryonic_growth_retardation | 1.14680097 |
| 69 | MP0005621_abnormal_cell_physiology | 1.13490832 |
| 70 | MP0000598_abnormal_liver_morphology | 1.13205976 |
| 71 | MP0002086_abnormal_extraembryonic_tissu | 1.12789988 |
| 72 | MP0001697_abnormal_embryo_size | 1.12088305 |
| 73 | MP0001944_abnormal_pancreas_morphology | 1.10602154 |
| 74 | MP0003448_altered_tumor_morphology | 1.10506598 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.09379037 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.09047246 |
| 77 | MP0005275_abnormal_skin_tensile | 1.08591218 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.07723961 |
| 79 | MP0004947_skin_inflammation | 1.07006911 |
| 80 | MP0008469_abnormal_protein_level | 1.06483462 |
| 81 | MP0003950_abnormal_plasma_membrane | 1.05746371 |
| 82 | MP0005408_hypopigmentation | 1.00988375 |
| 83 | MP0001661_extended_life_span | 1.00481850 |
| 84 | MP0000313_abnormal_cell_death | 1.00281770 |
| 85 | MP0003091_abnormal_cell_migration | 0.99738353 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.99502430 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.99382986 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.98212426 |
| 89 | MP0005384_cellular_phenotype | 0.97214063 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.96872177 |
| 91 | MP0010307_abnormal_tumor_latency | 0.96614996 |
| 92 | MP0009672_abnormal_birth_weight | 0.95017888 |
| 93 | MP0009785_altered_susceptibility_to | 0.94509043 |
| 94 | MP0005025_abnormal_response_to | 0.94450880 |
| 95 | MP0002419_abnormal_innate_immunity | 0.94231747 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.94197569 |
| 97 | MP0001243_abnormal_dermal_layer | 0.93856816 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.92776537 |
| 99 | MP0002118_abnormal_lipid_homeostasis | 0.92617268 |
| 100 | MP0001790_abnormal_immune_system | 0.92349051 |
| 101 | MP0005387_immune_system_phenotype | 0.92349051 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.91383867 |
| 103 | MP0004957_abnormal_blastocyst_morpholog | 0.91149687 |
| 104 | MP0000627_abnormal_mammary_gland | 0.91007470 |
| 105 | MP0001881_abnormal_mammary_gland | 0.90334789 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.89967135 |
| 107 | MP0000358_abnormal_cell_content/ | 0.89956152 |
| 108 | MP0005000_abnormal_immune_tolerance | 0.88962805 |
| 109 | MP0001800_abnormal_humoral_immune | 0.87848177 |
| 110 | MP0000537_abnormal_urethra_morphology | 0.87523425 |
| 111 | MP0000858_altered_metastatic_potential | 0.86764750 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.86522222 |
| 113 | MP0003890_abnormal_embryonic-extraembry | 0.86153238 |
| 114 | MP0002452_abnormal_antigen_presenting | 0.84792301 |
| 115 | MP0002006_tumorigenesis | 0.84559797 |
| 116 | MP0002933_joint_inflammation | 0.84146759 |
| 117 | MP0005671_abnormal_response_to | 0.83599007 |
| 118 | MP0001849_ear_inflammation | 0.82650744 |
| 119 | MP0002405_respiratory_system_inflammati | 0.82442949 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.82071714 |
| 121 | MP0003724_increased_susceptibility_to | 0.81418812 |
| 122 | MP0009763_increased_sensitivity_to | 0.81266320 |
| 123 | MP0000490_abnormal_crypts_of | 0.80590623 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.80361769 |
| 125 | MP0002148_abnormal_hypersensitivity_rea | 0.80210701 |
| 126 | MP0002723_abnormal_immune_serum | 0.80100440 |
| 127 | MP0001191_abnormal_skin_condition | 0.79971014 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.79681184 |
| 129 | MP0005503_abnormal_tendon_morphology | 0.79673595 |
| 130 | MP0002060_abnormal_skin_morphology | 0.79458376 |
| 131 | MP0005197_abnormal_uvea_morphology | 0.78490360 |
| 132 | MP0001873_stomach_inflammation | 0.78360465 |
| 133 | MP0002084_abnormal_developmental_patter | 0.77952839 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.77453412 |
| 135 | MP0002019_abnormal_tumor_incidence | 0.77388594 |
| 136 | MP0001756_abnormal_urination | 0.76324662 |
| 137 | MP0003795_abnormal_bone_structure | 0.76164362 |
| 138 | MP0000604_amyloidosis | 0.76116404 |
| 139 | MP0003718_maternal_effect | 0.75814983 |
| 140 | MP0002928_abnormal_bile_duct | 0.75747731 |
| 141 | MP0003279_aneurysm | 0.74641181 |
| 142 | MP0004197_abnormal_fetal_growth/weight/ | 0.73524604 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.73115181 |
| 144 | MP0005165_increased_susceptibility_to | 0.72845412 |
| 145 | MP0002420_abnormal_adaptive_immunity | 0.71639517 |
| 146 | MP0001764_abnormal_homeostasis | 0.71600195 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.71088901 |
| 148 | MP0001542_abnormal_bone_strength | 0.70800282 |
| 149 | MP0001819_abnormal_immune_cell | 0.70301019 |
| 150 | MP0002896_abnormal_bone_mineralization | 0.70066627 |
| 151 | MP0001958_emphysema | 0.70045973 |
| 152 | MP0000689_abnormal_spleen_morphology | 0.69449580 |
| 153 | MP0001915_intracranial_hemorrhage | 0.69039860 |
| 154 | MP0005257_abnormal_intraocular_pressure | 0.68789704 |
| 155 | MP0003763_abnormal_thymus_physiology | 0.67101369 |
| 156 | MP0001853_heart_inflammation | 0.66498150 |
| 157 | MP0009053_abnormal_anal_canal | 0.66374388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the intrinsic pathway (HP:0010989) | 3.91461529 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.82458025 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.78253473 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 3.68683952 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.64262179 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.58033232 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.41243021 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.35433129 |
| 9 | Dysostosis multiplex (HP:0000943) | 3.30852132 |
| 10 | Tetraparesis (HP:0002273) | 3.21367753 |
| 11 | Fat malabsorption (HP:0002630) | 3.18356604 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.18044579 |
| 13 | Xanthomatosis (HP:0000991) | 3.06855746 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04594617 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.04594617 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.04330942 |
| 17 | Premature rupture of membranes (HP:0001788) | 2.98750645 |
| 18 | Selective tooth agenesis (HP:0001592) | 2.87682711 |
| 19 | Steatorrhea (HP:0002570) | 2.82651314 |
| 20 | Multiple enchondromatosis (HP:0005701) | 2.82630766 |
| 21 | Cervical subluxation (HP:0003308) | 2.79657313 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77941486 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77941486 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77941486 |
| 25 | Prolonged partial thromboplastin time (HP:0003645) | 2.70359800 |
| 26 | Trismus (HP:0000211) | 2.67553420 |
| 27 | Rough bone trabeculation (HP:0100670) | 2.65629372 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61816352 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61816352 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61816352 |
| 31 | Complement deficiency (HP:0004431) | 2.60526219 |
| 32 | Beaking of vertebral bodies (HP:0004568) | 2.57169823 |
| 33 | Atrophic scars (HP:0001075) | 2.56954281 |
| 34 | Ketosis (HP:0001946) | 2.56767460 |
| 35 | Increased serum pyruvate (HP:0003542) | 2.56737673 |
| 36 | Myocardial infarction (HP:0001658) | 2.55232363 |
| 37 | Microvesicular hepatic steatosis (HP:0001414) | 2.53955483 |
| 38 | Abnormality of glycolysis (HP:0004366) | 2.46955896 |
| 39 | Achilles tendon contracture (HP:0001771) | 2.46353025 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45648355 |
| 41 | Hypoglycemic seizures (HP:0002173) | 2.45581285 |
| 42 | Overlapping toe (HP:0001845) | 2.41577945 |
| 43 | Ketoacidosis (HP:0001993) | 2.39048633 |
| 44 | Deviation of the thumb (HP:0009603) | 2.36095337 |
| 45 | Abnormality of the Achilles tendon (HP:0005109) | 2.34729797 |
| 46 | Upper limb muscle weakness (HP:0003484) | 2.33997473 |
| 47 | Amniotic constriction ring (HP:0009775) | 2.32828226 |
| 48 | Abnormality of placental membranes (HP:0011409) | 2.32828226 |
| 49 | Hypolipoproteinemia (HP:0010981) | 2.32418596 |
| 50 | Progressive muscle weakness (HP:0003323) | 2.31170114 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.31074191 |
| 52 | Peritonitis (HP:0002586) | 2.30548033 |
| 53 | Abnormal trabecular bone morphology (HP:0100671) | 2.29892891 |
| 54 | Cholecystitis (HP:0001082) | 2.27569009 |
| 55 | Abnormal gallbladder physiology (HP:0012438) | 2.27569009 |
| 56 | Sparse eyelashes (HP:0000653) | 2.26909901 |
| 57 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25754358 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.24555890 |
| 59 | Abnormality of complement system (HP:0005339) | 2.22680464 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22676431 |
| 61 | Late onset (HP:0003584) | 2.22305732 |
| 62 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.21920649 |
| 63 | Orthostatic hypotension (HP:0001278) | 2.20744518 |
| 64 | Nonimmune hydrops fetalis (HP:0001790) | 2.19757358 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.17857776 |
| 66 | Aplastic anemia (HP:0001915) | 2.17456867 |
| 67 | Gout (HP:0001997) | 2.17094176 |
| 68 | Hyperammonemia (HP:0001987) | 2.16290300 |
| 69 | Proximal placement of thumb (HP:0009623) | 2.16276604 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.16024532 |
| 71 | Abnormality of purine metabolism (HP:0004352) | 2.14826336 |
| 72 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14775114 |
| 73 | Secondary amenorrhea (HP:0000869) | 2.11223784 |
| 74 | Upper motor neuron abnormality (HP:0002127) | 2.10195450 |
| 75 | Insidious onset (HP:0003587) | 2.09037112 |
| 76 | Termporal pattern (HP:0011008) | 2.09037112 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08251475 |
| 78 | Back pain (HP:0003418) | 2.06345501 |
| 79 | Joint hemorrhage (HP:0005261) | 2.06298577 |
| 80 | Joint stiffness (HP:0001387) | 2.06190393 |
| 81 | Abnormality of oral frenula (HP:0000190) | 2.05661839 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.03750653 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.03743120 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.02700970 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.01242038 |
| 86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.00763701 |
| 87 | Thrombocytosis (HP:0001894) | 2.00707691 |
| 88 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.99167239 |
| 89 | Menorrhagia (HP:0000132) | 1.98338756 |
| 90 | Hyperlipoproteinemia (HP:0010980) | 1.97603627 |
| 91 | Mitral stenosis (HP:0001718) | 1.97378327 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 1.97318758 |
| 93 | Entropion (HP:0000621) | 1.97033403 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96956744 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.96956744 |
| 96 | Hyperglycinemia (HP:0002154) | 1.95582041 |
| 97 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.94454219 |
| 98 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.94454219 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93284993 |
| 100 | Abnormality of dentin (HP:0010299) | 1.93270813 |
| 101 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92101485 |
| 102 | Abnormality of the umbilical cord (HP:0010881) | 1.91982425 |
| 103 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.91518600 |
| 104 | Hepatocellular carcinoma (HP:0001402) | 1.89713342 |
| 105 | Abdominal distention (HP:0003270) | 1.88253715 |
| 106 | Vascular calcification (HP:0004934) | 1.87870571 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87682828 |
| 108 | Esophageal varix (HP:0002040) | 1.87671256 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.86895747 |
| 110 | Abnormal platelet function (HP:0011869) | 1.86895747 |
| 111 | Protuberant abdomen (HP:0001538) | 1.86688593 |
| 112 | Spastic diplegia (HP:0001264) | 1.86075093 |
| 113 | Cortical dysplasia (HP:0002539) | 1.85798372 |
| 114 | Symptomatic seizures (HP:0011145) | 1.85746235 |
| 115 | Elbow flexion contracture (HP:0002987) | 1.85143514 |
| 116 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84204193 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.84108828 |
| 118 | Abnormal tarsal ossification (HP:0008369) | 1.83024795 |
| 119 | Hypoalphalipoproteinemia (HP:0003233) | 1.82187578 |
| 120 | Onycholysis (HP:0001806) | 1.81908681 |
| 121 | Abnormal foot bone ossification (HP:0010675) | 1.81836252 |
| 122 | Hypokinesia (HP:0002375) | 1.81659915 |
| 123 | Sensorimotor neuropathy (HP:0007141) | 1.80006702 |
| 124 | Skin nodule (HP:0200036) | 1.79848364 |
| 125 | Short nail (HP:0001799) | 1.78979866 |
| 126 | Abnormal protein glycosylation (HP:0012346) | 1.78336203 |
| 127 | Abnormal glycosylation (HP:0012345) | 1.78336203 |
| 128 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.78336203 |
| 129 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.78336203 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 1.78279534 |
| 131 | Biconcave vertebral bodies (HP:0004586) | 1.78190434 |
| 132 | Aortic aneurysm (HP:0004942) | 1.77724834 |
| 133 | Gingival bleeding (HP:0000225) | 1.77221366 |
| 134 | Lower limb hyperreflexia (HP:0002395) | 1.76916598 |
| 135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76626526 |
| 136 | Fragile skin (HP:0001030) | 1.74541770 |
| 137 | Degeneration of anterior horn cells (HP:0002398) | 1.74258030 |
| 138 | Abnormality of the anterior horn cell (HP:0006802) | 1.74258030 |
| 139 | Abnormality of iron homeostasis (HP:0011031) | 1.74216423 |
| 140 | Decreased subcutaneous fat (HP:0001002) | 1.72699091 |
| 141 | Spastic paraparesis (HP:0002313) | 1.72476784 |
| 142 | Abnormality of the acetabulum (HP:0003170) | 1.72315036 |
| 143 | Shoulder girdle muscle weakness (HP:0003547) | 1.71949843 |
| 144 | Pancreatitis (HP:0001733) | 1.71949835 |
| 145 | Progressive external ophthalmoplegia (HP:0000590) | 1.71613194 |
| 146 | Petechiae (HP:0000967) | 1.71257483 |
| 147 | Increased serum ferritin (HP:0003281) | 1.70480195 |
| 148 | Abnormality of glycine metabolism (HP:0010895) | 1.70211945 |
| 149 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70211945 |
| 150 | Ankyloglossia (HP:0010296) | 1.70021175 |
| 151 | Small epiphyses (HP:0010585) | 1.69460256 |
| 152 | Oral leukoplakia (HP:0002745) | 1.67728116 |
| 153 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.66829466 |
| 154 | Blepharitis (HP:0000498) | 1.66232469 |
| 155 | Blue sclerae (HP:0000592) | 1.64650476 |
| 156 | Fasciculations (HP:0002380) | 1.64395449 |
| 157 | Abnormal delivery (HP:0001787) | 1.62747761 |
| 158 | Hepatosplenomegaly (HP:0001433) | 1.62301298 |
| 159 | Ankle contracture (HP:0006466) | 1.61293721 |
| 160 | Bone pain (HP:0002653) | 1.61157441 |
| 161 | Progressive hearing impairment (HP:0001730) | 1.60510345 |
| 162 | Premature ovarian failure (HP:0008209) | 1.60298958 |
| 163 | Pelvic girdle muscle weakness (HP:0003749) | 1.60252544 |
| 164 | Abnormality of carpal bone ossification (HP:0006257) | 1.59434316 |
| 165 | Elevated alkaline phosphatase (HP:0003155) | 1.58464869 |
| 166 | Pseudobulbar signs (HP:0002200) | 1.57739077 |
| 167 | Flat acetabular roof (HP:0003180) | 1.56639678 |
| 168 | Increased nuchal translucency (HP:0010880) | 1.55904042 |
| 169 | Right ventricular cardiomyopathy (HP:0011663) | 1.55557767 |
| 170 | Loss of speech (HP:0002371) | 1.54775197 |
| 171 | Pterygium (HP:0001059) | 1.54743271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.11420319 |
| 2 | EIF2AK1 | 3.01063074 |
| 3 | BCKDK | 2.87765688 |
| 4 | TRIB3 | 2.80361980 |
| 5 | EIF2AK3 | 2.60258006 |
| 6 | NME2 | 2.56328357 |
| 7 | TSSK6 | 2.51878370 |
| 8 | FLT3 | 2.39582805 |
| 9 | PKN2 | 2.19876620 |
| 10 | RPS6KA4 | 1.97587550 |
| 11 | NEK1 | 1.93241201 |
| 12 | PDK2 | 1.93002715 |
| 13 | TTK | 1.88144934 |
| 14 | KDR | 1.87109070 |
| 15 | TAOK3 | 1.85237422 |
| 16 | CDK12 | 1.80869462 |
| 17 | ZAP70 | 1.76612247 |
| 18 | MAP4K1 | 1.75226524 |
| 19 | SCYL2 | 1.71739338 |
| 20 | FGFR4 | 1.71697051 |
| 21 | JAK3 | 1.58656446 |
| 22 | STK10 | 1.53812362 |
| 23 | TESK2 | 1.52915057 |
| 24 | TBK1 | 1.52655982 |
| 25 | PTK6 | 1.50882349 |
| 26 | LATS2 | 1.49862006 |
| 27 | SIK1 | 1.47747610 |
| 28 | MAP3K3 | 1.46649549 |
| 29 | FRK | 1.45296743 |
| 30 | SIK3 | 1.42228861 |
| 31 | MAP3K12 | 1.40515112 |
| 32 | EPHB1 | 1.39988111 |
| 33 | SMG1 | 1.38300847 |
| 34 | PASK | 1.34165830 |
| 35 | TYK2 | 1.33900017 |
| 36 | VRK2 | 1.33456240 |
| 37 | LRRK2 | 1.31362495 |
| 38 | TESK1 | 1.29217174 |
| 39 | MAP3K10 | 1.28232819 |
| 40 | MET | 1.24628491 |
| 41 | NEK9 | 1.22097434 |
| 42 | BLK | 1.21327375 |
| 43 | PIM2 | 1.20581002 |
| 44 | IRAK4 | 1.16847240 |
| 45 | ARAF | 1.06788430 |
| 46 | BUB1 | 1.05159320 |
| 47 | PDGFRA | 1.04084217 |
| 48 | PAK4 | 1.02997392 |
| 49 | JAK1 | 1.01444242 |
| 50 | PLK3 | 1.00827244 |
| 51 | LIMK1 | 0.97507857 |
| 52 | MOS | 0.97306526 |
| 53 | STK16 | 0.97059033 |
| 54 | PRPF4B | 0.96150268 |
| 55 | MKNK1 | 0.95786005 |
| 56 | MAP3K8 | 0.95611021 |
| 57 | EPHA2 | 0.94645829 |
| 58 | IRAK3 | 0.94156007 |
| 59 | CSK | 0.91533836 |
| 60 | KIT | 0.90965648 |
| 61 | BCR | 0.90459637 |
| 62 | TAOK2 | 0.90048243 |
| 63 | BTK | 0.87404340 |
| 64 | MAP2K3 | 0.86712758 |
| 65 | CSF1R | 0.86504360 |
| 66 | INSRR | 0.86367201 |
| 67 | ALK | 0.84346875 |
| 68 | NEK2 | 0.84047132 |
| 69 | BRSK1 | 0.82829827 |
| 70 | EPHA3 | 0.82822177 |
| 71 | CLK1 | 0.81662643 |
| 72 | TTN | 0.80833889 |
| 73 | TAF1 | 0.80444562 |
| 74 | PTK2 | 0.79708591 |
| 75 | STK3 | 0.79494307 |
| 76 | MST1R | 0.78234715 |
| 77 | LATS1 | 0.77487782 |
| 78 | PLK1 | 0.77361297 |
| 79 | PAK2 | 0.77162511 |
| 80 | CHEK1 | 0.76837320 |
| 81 | PIK3CG | 0.76550395 |
| 82 | EEF2K | 0.76480943 |
| 83 | IKBKE | 0.75913588 |
| 84 | CDK9 | 0.75681465 |
| 85 | TGFBR2 | 0.74756478 |
| 86 | MST4 | 0.74631772 |
| 87 | WEE1 | 0.74088755 |
| 88 | ITK | 0.73685476 |
| 89 | BRSK2 | 0.72060790 |
| 90 | MAP2K2 | 0.70044491 |
| 91 | EIF2AK2 | 0.69330724 |
| 92 | MAP3K11 | 0.67904165 |
| 93 | CDC7 | 0.65855293 |
| 94 | JAK2 | 0.65505972 |
| 95 | MKNK2 | 0.64933282 |
| 96 | BRD4 | 0.64735612 |
| 97 | MAP3K14 | 0.61078369 |
| 98 | ATR | 0.61050734 |
| 99 | BRAF | 0.61010069 |
| 100 | NME1 | 0.60821441 |
| 101 | AURKA | 0.59600266 |
| 102 | PIM1 | 0.57169217 |
| 103 | DDR2 | 0.57067757 |
| 104 | RIPK1 | 0.55727454 |
| 105 | MAP3K5 | 0.54416159 |
| 106 | ILK | 0.54264958 |
| 107 | CHEK2 | 0.54096757 |
| 108 | CDK8 | 0.53842017 |
| 109 | STK24 | 0.53330859 |
| 110 | MTOR | 0.52620005 |
| 111 | DMPK | 0.51271535 |
| 112 | TRIM28 | 0.50462047 |
| 113 | LYN | 0.49808425 |
| 114 | ERBB3 | 0.49632398 |
| 115 | IKBKB | 0.49551215 |
| 116 | CDK4 | 0.48453515 |
| 117 | CDK6 | 0.48429069 |
| 118 | NUAK1 | 0.48308739 |
| 119 | PDGFRB | 0.48255120 |
| 120 | FGFR3 | 0.47674047 |
| 121 | YES1 | 0.47091878 |
| 122 | CHUK | 0.46941257 |
| 123 | ABL2 | 0.46899713 |
| 124 | CSNK2A2 | 0.46615910 |
| 125 | ICK | 0.46345666 |
| 126 | CSNK2A1 | 0.46088629 |
| 127 | PLK4 | 0.45691375 |
| 128 | MAPKAPK3 | 0.44534688 |
| 129 | LCK | 0.43512752 |
| 130 | DYRK1B | 0.43174018 |
| 131 | AURKB | 0.42962488 |
| 132 | TGFBR1 | 0.42589660 |
| 133 | MAPK15 | 0.42309357 |
| 134 | RPS6KB2 | 0.42289643 |
| 135 | SRPK1 | 0.42274113 |
| 136 | TEC | 0.41818592 |
| 137 | ERBB4 | 0.40721585 |
| 138 | HIPK2 | 0.39755756 |
| 139 | STK4 | 0.38613263 |
| 140 | PBK | 0.38370295 |
| 141 | IRAK1 | 0.38163315 |
| 142 | IRAK2 | 0.38028774 |
| 143 | SYK | 0.37638730 |
| 144 | CDK7 | 0.37080284 |
| 145 | MAPK11 | 0.36971093 |
| 146 | MELK | 0.36875075 |
| 147 | NTRK1 | 0.32681657 |
| 148 | MAPKAPK2 | 0.31118089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.77579029 |
| 2 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.95877214 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.74380499 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56021924 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48539084 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.34947529 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22826603 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17643740 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.11381444 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.10729458 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.01922473 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 1.97837100 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77900595 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.77494903 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.72265282 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71087077 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.69742358 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69254518 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68400452 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65685367 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.65197380 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 1.60296032 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58826589 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57789358 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55289611 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.52991623 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51555002 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42007560 |
| 29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41783873 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40538942 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.38069165 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33595571 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27623015 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.27492481 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.27155169 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26096793 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25016097 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15784812 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15725548 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.13817686 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.11772386 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11644477 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.11569977 |
| 44 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10849205 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08379700 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07976042 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07369454 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06164335 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03808715 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.02185625 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00792441 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.00379723 |
| 53 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99921999 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99890616 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99249409 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98356089 |
| 57 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97749112 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96078345 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95288809 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94390968 |
| 61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92303895 |
| 62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90300314 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89750669 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89227310 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88735571 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88008494 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87792790 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86893071 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84602349 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82335877 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81040727 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.81016506 |
| 73 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80476342 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79185838 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78821003 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78319908 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78312140 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76900380 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75996241 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75660935 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74117236 |
| 82 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73848153 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71124822 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70009138 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68689989 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66836042 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.65059012 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64322607 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.64244347 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62905462 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62244396 |
| 92 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61590821 |
| 93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58810022 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57204838 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55797604 |
| 96 | Homologous recombination_Homo sapiens_hsa03440 | 0.55331079 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54864638 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.54667141 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54429221 |
| 100 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54179076 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51232406 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51202179 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51161774 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.50713199 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.50007514 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48853294 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.48680039 |
| 108 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48567846 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.48147616 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.47720878 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47143587 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45457565 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45046905 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44602156 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44208904 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.43291073 |
| 117 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42124832 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.41880405 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41687459 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40974459 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40396667 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40216929 |
| 123 | Measles_Homo sapiens_hsa05162 | 0.40151107 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.40041664 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.38574383 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.38400704 |
| 127 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38224849 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37796171 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37717035 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.37676959 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37615870 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36751783 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.36559217 |
| 134 | Bile secretion_Homo sapiens_hsa04976 | 0.35397099 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.34770176 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34445739 |
| 137 | Adherens junction_Homo sapiens_hsa04520 | 0.34293542 |
| 138 | RNA transport_Homo sapiens_hsa03013 | 0.34185716 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.33299663 |
| 140 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.32801021 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.32641545 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32259924 |
| 143 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30539340 |

